Life science leader executive editor blog Life science leader executive editor blog

Night Of Light: California Life Science Association (CLSA)
Night Of Light: California Life Science Association (CLSA) Because I live only a day-trip away from San Francisco, it is convenient for me to travel there for industry events — a trek always accompanied by reflective reveries for the hometown of my film-student days. So, for the third time since June, and with another week scheduled for early January, I am once again city-bound, leaving home mid-day and getting into my hotel in plenty of time to make the 5:30 PM reception for the annual Pantheon...  Continue Reading...
BIO Shines In San Francisco
BIO Shines In San Francisco This year, the BIO Investor Forum (#BIF16) in San Francisco enjoyed its largest turnout ever, basked in the light and warmth of a dynamic industry that may not solve all of the world’s problems, but shines upon us, a salubrious star. Will the industry’s star shine upon everyone, or leave most of humanity in the shadows?  Continue Reading...
IO: Science Still Drives The Business
IO: Science Still Drives The Business How much science does a business person need to know? In this industry, the more the better. Without at least an excellent layperson’s understanding of the company’s scientific underpinnings, a life science executive will remain vulnerable to the greatest of all hazards in managing the business — today’s news.  Continue Reading...
Living With Pricing
Living With Pricing Life Science Leader Launches a Search for Common Ground  Continue Reading...
BIO Still Delivers
BIO Still Delivers If the BIO International Convention did nothing but assemble the 16,000 people who came to this year’s meeting in San Francisco, simply giving them a space to talk, that alone would be a great achievement.  Continue Reading...
An Absent Life Science Blogger’s Backstory
An Absent Life Science Blogger’s Backstory Alas, I am a specialized ignoramus, or dilettante; aka, a journalist. To ask even the most basic questions about the series topic — generally, new therapeutic approaches to neurodegenerative diseases — I first put myself through a veritable college course on the subject, reading and rereading through a tall (cyber) pile of related scientific, medical, and commercial literature. And yet, it is not the unseen labor I regret, but the...  Continue Reading...
Write Thinking — Biopharma At the Turn of the Year
Write Thinking — Biopharma At the Turn of the Year Writing is reinforced thinking. It is a stronger, more constructive way of moving through the thought world. Because I am a trade journalist covering the life science industry, all of those things tend to appear to me in industry terms. Take the drug-pricing debate, for example.     Continue Reading...
Startups & Outsourcing — Opposite Poles or Virtual Partners?
Startups & Outsourcing — Opposite Poles or Virtual Partners? Let’s face it, finding the money often captures all but a few crumbs of the typical startup CEO’s attention. Laser-sharp illustrations in the company’s dog-and-pony show may present its scientific platform with convincing clarity and purpose, but traditionally, investment conferences have not been a place where the dollar-hungry startup talks about the infrastructure it must build or hire to turn its science into a medical...  Continue Reading...
Reliving the Past, Shaping the Future of Cancer Therapy
Reliving the Past, Shaping the Future of Cancer Therapy A news item on AZ’s new “crowdsourcing” approach to cancer-drug treatment. The report uncritically hailed the program as a veritable revolution in cancer therapy that could yield greatly improved results from combinations of traditional chemotherapeutics and, presumably, other approved drugs with different modalities such as molecular-pathway targeting.  Continue Reading...
Was It the Weather? — Why Biotech Came from California
Was It the Weather? — Why Biotech Came from California Could climate have played as big a role as science and capital in the origins of the biotechnology industry? The question is about beginning: did this brand new industry need that extra push of a beneficent clime to overcome the unlikelihood of such a business ever being born?  Continue Reading...

BE A CONTRIBUTOR